---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-009224"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2024-03-07T23:59:59+00:00"
generated_at: "2026-06-05T01:40:26.125667+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# AgeX draws $500K, sets warrant dividend and reverse split for Serina merger

## Summary
- Drew $500,000 under secured convertible note with Juvenescence; repayment due May 9, 2024.
- Declared warrant dividend: three Post-Merger Warrants per five shares held, exercise price $13.20, expiring July 31, 2025.
- Reverse stock split expected March 14, 2024; trading on split-adjusted basis March 15, 2024.
- Special meeting on March 14, 2024 to vote on warrant dividend and reverse stock split.

## SEC filing metadata
- accession: 0001493152-24-009224
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2024-03-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.03, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315224009224/0001493152-24-009224-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315224009224/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-009224
- JSON: https://secwatch.observer/filing/0001493152-24-009224.json
- Plain text: https://secwatch.observer/filing/0001493152-24-009224.txt

## Key facts
- Debt Financings
  Serina Therapeutics, Inc. incurred loan of $500,000 with Juvenescence Limited maturing May 9, 2024.
  - Instrument: loan
  - Principal: $500,000
  - Counterparty: Juvenescence Limited
  - Maturity: May 9, 2024
  - Event: incurrence
  source text: On March 5, 2024, AgeX Therapeutics, Inc., a Delaware corporation (“AgeX”), drew $500,000 of its credit available under the Amended and Restated Secured Convertible Promissory Note, as amended ( the “Secured Note”), with Juvenescence Limited.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315224009224/0001493152-24-009224-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.